 |
|
The Case for Observational Management of Suspected Small Choroidal Melanoma
Arch Ophthalmol. 2006;124:1342-1344.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In December 1997, the ARCHIVES reported the outcome of the Collaborative Ocular Melanoma Study small tumor observational study documenting factors predictive of growth and treatment in this multicenter clinical trial.1 Accompanying that issue was an editorial that delineated the pros and cons to observation vs early treatment for small choroidal melanoma.2 In that editorial, an argument was made for a randomized clinical trial to definitively address the critical clinical question, "Do I treat now or do I wait?" Now approaching the latter half of a decade from this discussion, we as the ophthalmologists managing patients with suspected small choroidal melanomas are still faced with the dilemma as to the best treatment approach for these patients.
Recent advances in clinical oncology and in ocular oncology have focused on delivering early, targeted, definitive therapy to primary malignancies. Cutaneous melanoma management has benefited from aggressive screening programs to identify suspicious lesions, to . . . [Full Text of this Article]
AUTHOR INFORMATION
Timothy G. Murray, MD;
Lucia Sobrin, MD
Author Affiliations: Ocular Oncology Service, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla (Dr Murray); and Massachusetts Eye and Ear Infirmary, Boston (Dr Sobrin).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Role of Cytogenetics in Management of Uveal Melanoma
Shields et al.
Arch Ophthalmol 2008;126:416-419.
FULL TEXT
Measurement of Human Choroidal Melanoma Xenograft Volume in Rats Using High-Frequency Ultrasound
Braun and Vistisen
IOVS 2008;49:16-22.
ABSTRACT
| FULL TEXT
|
